BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 24, 2012
View Archived Issues
Merz Pharma designs novel modulators of mGlu5 receptors
Read More
New gamma-secretase modulator shows promise as a cognition-enhancing drug
Read More
New method allows drug safety predictions early in drug discovery process
Read More
Korean researchers present new siRNA compositions
Read More
Gene Signal International discloses novel agents for cancer
Read More
Novel drug candidates for Alzheimer's disease presented
Read More
Leo Pharma designs new ingenol derivatives
Read More
Memorial Sloan-Kettering center launches stem cell trial for beta-thalassemia
Read More
Qu Biologics planning phase I/II study in Crohn's disease
Read More
FDA approves product for long-term maintenance treatment of COPD
Read More
Antisense Therapeutics provides update on ATL-1101
Read More
Celgene to request reexamination of CHMP opinion on Istodax MAA
Read More
Oxford BioMedica receives funding for ongoing UshStat study
Read More
French team synthesizes novel potassium channel blockers
Read More
CHMP issues opinion on Dacogen
Read More
BrainStorm Cell Therapeutics reports encouraging interim data on NurOwn
Read More
NeuroPhage Alzheimer's disease candidate drug set to enter clinic
Read More
Collaborating organizations in Belgium and France patent new agents for AIDS
Read More
Repros provides update on phase II uterine fibroid trial
Read More
Faes Farma out-licenses antiallergy product in Japan
Read More
Synergy Pharmaceuticals enters definitive merger agreement
Read More
Gene variants may predict fibrosis risk after liver transplant for hepatitis C
Read More
BG Medicine files for FDA clearance of ARCHITECT Galectin-3 assay
Read More
Berg Pharma kicks off phase I trial of BPM-31543
Read More
Enrollment complete in pivotal CompleoTRT trial
Read More
Treatment begins in phase II trial of Cerulean's lead product
Read More
Phase I trial of XenoPort candidate for RRMS and psoriasis commences
Read More